🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Southeast University, China clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with Southeast University, China as lead sponsor. Synced 26 Sep 2026
20Current trials
14Recruiting now
1Drug in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Southeast University, China is the lead sponsor of 20 current clinical trials in our China register. 14 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Dexamethasone. The most-studied condition is Acute Respiratory Distress Syndrome.

ClinicalTrials.gov trials by status

  • Recruiting1470%
  • Not yet open525%
  • By invitation15%

Trials by phase

  • Observational1050%
  • Not applicable840%
  • Phase 3210%
01

Clinical trials sponsored by Southeast University, China

20 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Efficacy and Safety of Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infection
NCT06051513 · ClinicalTrials.gov ↗ · Carbapenem-Resistant Enterobacteriaceae Infection
Not applicable Recruiting 2023-11 China
Inhaled Colistin to Prevent Ventilator-Associated Pneumonia in Patients With Acute Brain Injury
NCT06819462 · ClinicalTrials.gov ↗ · Ventilator-Associated Pneumonia (VAP), Inha'le'd
Not applicable Recruiting 2025-04 China
OR6A2 on Monocytes and Cardiovascular Outcomes in Myocardial Ischemia-Reperfusion Injury
NCT07100457 · ClinicalTrials.gov ↗ · Myocardial Ischemia-Reperfusion Injury
Observational Recruiting 2019-09 China
Full-Course ECMO Strategy for Moderate-to-Severe ARDS
NCT07726953 · ClinicalTrials.gov ↗ · Acute Respiratory Distress Syndrome
Not applicable Recruiting 2026-06 China
Effect of Remimazolam Sedation on Outcomes of Mechanically Ventilated Patients in the ICU
NCT07596589 · ClinicalTrials.gov ↗ · Remimazolam Besylate, Mechanically Ventilated ICU Patients, Sedation
Phase 3 Recruiting 2025-04 China
The Physiological Effect of RCexp on Ventilation/Perfusion Distribution
NCT06919484 · ClinicalTrials.gov ↗ · Acute Respiratory Distress Syndrome, Mechanical Ventilation
Observational Recruiting 2025-11 China
Effect of EIT-guided PEEP in ARDS Patients
NCT06990477 · ClinicalTrials.gov ↗ · ARDS (Acute Respiratory Distress Syndrome)
Not applicable Recruiting 2026-03 China
Effects of Face Mask Continuous Positive Airway Pressure Vs. Noninvasive Ventilation Vs. High-flow Nasal Oxygen on Intubation-free Survival in Acute Hypoxemic Respiratory Failure: the TRIPOD Randomized Clinical Trial
NCT06795971 · ClinicalTrials.gov ↗ · Acute Hypoxemic Respiratory Failure, High-Flow Nasal Oxygen Therapy, Noninvasive Ventilation
Not applicable Recruiting 2025-01 China
Practices of Prone Positioning Ventilation in Patients With Moderate-to-Severe ARDS in Intensive Care Units: A Registry-Based Observational Study
NCT07284888 · ClinicalTrials.gov ↗ · Acute Respiratory Distress Syndrome
Observational Recruiting 2026-01 China
Validation and Precision Treatment of Inflammatory Subphenotypes in Acute Respiratory Distress Syndrome: A Multicenter Cohort Study
NCT07289711 · ClinicalTrials.gov ↗ · Acute Respiratory Distress Syndrome
Observational Recruiting 2025-12 China
Immune Mechanisms and ECMO Strategies for Moderate-to-Severe ARDS
NCT07726940 · ClinicalTrials.gov ↗ · Acute Respiratory Distress Syndrome (ARDS)
Observational Recruiting 2026-06 China
Dexamethasone Treatment for Sepsis-associated Acute Respiratory Distress Syndrome: a Multicenter, Randomised, Double-blinded, Controlled Trial
NCT07576660 · ClinicalTrials.gov ↗ · Acute Respiratory Distress Syndrome (ARDS)
Phase 3 Recruiting 2026-08 China
Effect of Early Transition to Assisted Ventilation on 28-day Successful Extubation in Critically Ill Patients
NCT07519512 · ClinicalTrials.gov ↗ · Mechanical Ventilator Care
Not applicable Recruiting 2026-08 China
Enteral Nutrition Delivery in Prone Position Ventilated Patients With Moderate to Severe ARDS
NCT07362537 · ClinicalTrials.gov ↗ · ARDS
Not applicable Recruiting 2026-01 China
Outcomes of Sepsis Patients in China (CHINA-SEP)
NCT07066553 · ClinicalTrials.gov ↗ · Sepsis
Observational Not yet open 2025-07 China
Cyclic On-off Switching of Pulmonary Blood Flow in Moderate to Severe ARDS
NCT07327268 · ClinicalTrials.gov ↗ · ARDS (Acute Respiratory Distress Syndrome), Electrical Impedance Tomography (EIT), Pulmonary Perfusion
Observational Not yet open 2026-01 China
Effect of Xuebijing InjecTion on Outcomes in Sepsis Patients Under Real-World Conditions(EXIT-SEP REAL)
NCT07069894 · ClinicalTrials.gov ↗ · Sepsis
Observational Not yet open 2025-08 China
Anti-Bloating Patch for Postoperative Gastric Distension After Cardiac Surgery
NCT07677423 · ClinicalTrials.gov ↗ · Postoperative Gastric Distension, Postoperative Gastrointestinal Dysfunction, Cardiac Surgery
Not applicable Not yet open 2026-07 China
Dynamic Multimodal Delirium Warning After Cardiac Surgery
NCT07686900 · ClinicalTrials.gov ↗ · Postoperative Delirium, Cardiac Surgical Procedures
Observational Not yet open 2026-07 China
Consistency of Fluid Tolerance Evaluation Methods and Their Correlation With Clinical Outcomes in Patients With Shock
NCT07373717 · ClinicalTrials.gov ↗ · Shock
Observational By invitation 2025-11 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Southeast University, China trials

1 compound

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Southeast University, China trials

26 conditions
Acute Respiratory Distress Syndrome4ARDS (Acute Respiratory Distress Syndrome)2Sepsis2Acute Respiratory Distress Syndrome (ARDS)2Carbapenem-Resistant Enterobacteriaceae Infection1Ventilator-Associated Pneumonia (VAP)1Inha'le'd1Myocardial Ischemia-Reperfusion Injury1Remimazolam Besylate1Mechanically Ventilated ICU Patients1Sedation1Mechanical Ventilation1Acute Hypoxemic Respiratory Failure1High-Flow Nasal Oxygen Therapy1Noninvasive Ventilation1Continuous Positive Airway Pressure (CPAP)1Electrical Impedance Tomography (EIT)1Pulmonary Perfusion1Mechanical Ventilator Care1Postoperative Gastric Distension1Postoperative Gastrointestinal Dysfunction1Cardiac Surgery1Postoperative Delirium1Cardiac Surgical Procedures1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in China2014

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Acute Respiratory Distress Syndrome

SponsorTrials
Direct Biologics1

Sponsors with the most current trials registered for this condition.

06

Questions about Southeast University, China trials

How many clinical trials does Southeast University, China sponsor?

Southeast University, China is the lead sponsor of 20 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Southeast University, China trials recruiting?

Yes. 14 of its 20 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Southeast University, China testing?

Its current trials name 1 drug or biological as interventions. The most frequent are Dexamethasone (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.